Biotechs Like Genzyme Corporation Have Big Appeal For Drug Makers, Deals Indicate Move to Boost Product Portfolio

Boston Globe -- Genzyme Corp., which is locked in merger talks with French drug maker Sanofi-Aventis SA, is not the first major Massachusetts biotechnology company to be pursued by a major pharmaceutical company. And it likely will not be the last.